Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kerendia
Kerendia
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Mon, 10/16/23 - 10:24 am
Novo Nordisk
KBP Biosciences
Bayer
chronic kidney disease
Kerendia
ocedurenone
hypertension
Bayer looks to expand Kerendia label to include heart failure
Clinical Trials Arena
Fri, 09/1/23 - 12:38 pm
Bayer
Kerendia
clinical trials
heart failure
JPM23: Bayer hikes sales targets for Kerendia, Nubeqa to $3B each
Fierce Pharma
Tue, 01/10/23 - 06:35 pm
Bayer
JPMHC 2023
Kerendia
prostate cancer
Nubeqa
Positive data on Kerendia in chronic kidney disease and type 2 diabetes
Pharma Letter
Mon, 08/29/22 - 10:38 am
Bayer
Kerendia
chronic kidney disease
ESCC
ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia
Fierce Pharma
Tue, 06/7/22 - 10:13 am
ADA
diabetes
Bayer
chronic kidney disease
Kerendia
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients
Fierce Pharma
Mon, 04/4/22 - 11:20 pm
Bayer
ACC
kidney disease
Kerendia
ESC 2021: Bayer's Kerendia touts outcomes data as it looks to complement J&J, AZ drugs
Fierce Pharma
Sat, 08/28/21 - 09:02 pm
Bayer
ESC
finerenone
Kerendia
FDA
clinical trials
kidney disease
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
FDA
drug approvals
Bayer
Kerendia
Astellas
Padcev
Teva Pharmaceutical
ArmonAir RespiClick
Janssen
Darzalex Faspro
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga